Reni Benjamin

Stock Analyst at JMP Securities

(1.43)
# 3,502
Out of 5,030 analysts
173
Total ratings
40.56%
Success rate
-14.25%
Average return

Stocks Rated by Reni Benjamin

Allogene Therapeutics
Aug 4, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $1.23
Upside: -
Inhibrx Biosciences
May 15, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $37.36
Upside: -
Bicycle Therapeutics
May 2, 2025
Maintains: Market Outperform
Price Target: $26$22
Current: $8.17
Upside: +169.28%
Cue Biopharma
Apr 2, 2025
Reiterates: Market Outperform
Price Target: $2
Current: $0.80
Upside: +151.19%
BioAtla
Mar 31, 2025
Maintains: Market Outperform
Price Target: $5$1
Current: $0.83
Upside: +20.53%
Incyte
Mar 11, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $87.57
Upside: -
Adicet Bio
Mar 7, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $0.99
Upside: -
Werewolf Therapeutics
Jan 14, 2025
Maintains: Market Outperform
Price Target: $12$4
Current: $1.60
Upside: +150.00%
Compugen
Aug 8, 2022
Maintains: Market Outperform
Price Target: $8$4
Current: $1.88
Upside: +113.33%
Adverum Biotechnologies
Nov 12, 2020
Upgrades: Market Perform
Price Target: n/a
Current: $4.29
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $1.37
Upside: -
Reinstates: Market Perform
Price Target: n/a
Current: $6.56
Upside: -
Maintains: Outperform
Price Target: $20$16
Current: $0.20
Upside: +7,896.00%
Maintains: Outperform
Price Target: $11$10
Current: $14.36
Upside: -30.36%
Reiterates: Market Outperform
Price Target: $5
Current: $5.03
Upside: -0.60%
Reiterates: Market Outperform
Price Target: $28
Current: $9.84
Upside: +184.55%
Reiterates: Market Perform
Price Target: n/a
Current: $19.09
Upside: -
Reiterates: Market Outperform
Price Target: $40
Current: $20.99
Upside: +90.57%
Reiterates: Market Perform
Price Target: n/a
Current: $1.48
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $2.18
Upside: -
Reiterates: Market Outperform
Price Target: $4
Current: $1.19
Upside: +236.13%
Downgrades: Market Perform
Price Target: n/a
Current: $1.01
Upside: -
Maintains: Market Outperform
Price Target: $7$8
Current: $8.98
Upside: -10.91%
Reiterates: Market Outperform
Price Target: $60
Current: $46.25
Upside: +29.73%
Reiterates: Market Perform
Price Target: n/a
Current: $8.29
Upside: -
Reiterates: Market Outperform
Price Target: $315
Current: $234.25
Upside: +34.47%
Reiterates: Market Perform
Price Target: n/a
Current: $92.30
Upside: -
Reiterates: Market Outperform
Price Target: $265
Current: $240.21
Upside: +10.32%
Downgrades: Outperform
Price Target: $28$17
Current: $4.95
Upside: +243.43%
Downgrades: Market Perform
Price Target: n/a
Current: $0.55
Upside: -
Reinstates: Outperform
Price Target: n/a
Current: $11.73
Upside: -
Upgrades: Market Perform
Price Target: n/a
Current: $1.65
Upside: -
Downgrades: Outperform
Price Target: $22$12
Current: $34.67
Upside: -65.39%
Downgrades: Market Perform
Price Target: n/a
Current: $16.94
Upside: -